COMMUNIQUÉS West-GlobeNewswire

Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
21/08/2026
ADELAIDE, Australia, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing international biotechs, today announced the appointment of Tim [...]
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
21/08/2026
U.S. Patent 12,679,817, covering novel processes for preparing the (R)- and (S)-enantiomers of MDMA and MBDB, granted to PharmAla by the US Patent and Trademark Office (USPTO) PharmAla has exercised its option to cancel [...]
European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab for relapsed/refractory multiple myeloma, offering a potential new standard of care
21/08/2026
Approval is based on unprecedented Phase 3 data showing statistically significant improvements in progression-free and overall survival versus standard of care regimens 1 This immunotherapy doublet regimen demonstrated [...]
NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation
21/08/2026
National Institute for Health and Care Excellence (NICE) guidance supports wider patient access to life-saving liver transplantation through routine adoption of machine perfusion technologies across England OXFORD, [...]
Bavarian Nordic Reports Strong First Half 2026 Results
21/08/2026
COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the second quarter and first half of 2026 and released its financial [...]
Bavarian Nordic to Launch New Share Buy-back Program of up to DKK 750 Million
21/08/2026
Repurchased shares will be subject to cancellation, pending shareholder resolution COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced its plans to launch a new share buy-back program [...]
Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance
21/08/2026
Guidance upgrade reflects upper end of previous guided revenue range and an improved EBITDA margin COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an upgrade of the Company’s [...]
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
21/08/2026
PARIS, FRANCE, 21 AUGUST 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor [...]
Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée
21/08/2026
PARIS, FRANCE, 21 AOUT 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) a annoncé aujourd’hui avoir finalisé l'acquisition de Kartos Therapeutics, une société biopharmaceutique au stade clinique, apportant le navtemadlin, un [...]
Aveanna Announces Pricing of Secondary Offering of Common Stock
21/08/2026
ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, [...]
Keystone Substance Abuse Services Rebrands as Keystone Behavioral Health, Expanding Behavioral Health Services in York County
21/08/2026
Rebrand reflects expanded behavioral health services alongside continued substance misuse prevention, intervention, treatment and recovery programs; ribbon cutting set for August 21 in Rock Hill, S.C. Rock Hill, SC, Aug [...]
NurExone Announces Closing of C$1,066,078 Private Placement
20/08/2026
TORONTO, and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biopharmaceutical company developing exosome-based [...]
BioSyent Declares Third Quarter 2026 Dividend
20/08/2026
MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.055 per [...]
BioSyent Releases Financial Results for Q2 and H1 2026
20/08/2026
MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve [...]
Aveanna Announces Launch of Secondary Offering of Common Stock
20/08/2026
ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, [...]
The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
20/08/2026
SAN JUAN CAPISTRANO, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/08/2026
WALTHAM, Mass., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
20/08/2026
CONSHOHOCKEN, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
20/08/2026
Woburn, MA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples [...]

Pages